Dual-effect Acomplia (Rimonabant)

Change at the top

admin — Mon, 06 Oct 2008 08:02:28 +0000

This week has seen real drama in the boardroom of Sanofi-Aventis, the company that manufactures the weight loss medication Acomplia so popular in Europe. This company is the third largest pharmaceutical manufacturer by sales in the world. After reports of discord at the top and rumors of a shareholder revolt by Total and L’Oreal, the CEO has stepped down and has been replaced by a senior executive headhunted from GlaxoSmithKline. (more…)

What’s in a name? What about cannabis?

admin — Mon, 18 Aug 2008 21:36:25 +0000

On 15th July, the Federation of European Pharmacological Societies Congress began a discussion of the medicinal role of cannabis. It is routinely used for controlling nausea among patients on chemotherapy and for encouraging appetite among AIDS patients. It is now licensed for the control of neuropathic pain in adults suffering from cancer and multiple sclerosis. So medical science has been able to strip away the “unwanted” psychoactive symptoms and use the cannabinoid components to target the specific diseases. (more…)

The Brits want more acomplia

admin — Fri, 01 Aug 2008 22:42:36 +0000

Those nice people from the National Institute for Health and Clinical Excellence (NICE) have issued new guidelines to doctors in the UK recommending they make greater use of Acomplia. NICE has the responsibility of leading the fight against obesity. It has adopted a national policy that urgent action is needed, but there are only a few treatments considered suitable for patients. (more…)

Cessation of smoking with the help of diet pills

admin — Fri, 25 Jul 2008 14:46:42 +0000

If you are trying to lose weight, but feel that it’s pointless because you smoke, now’s your chance to take advantage of the advances made in the medical field. Acomplia is a doctor prescribed medication that has made advances in the field of medication. Approved in the European Union in 2006, this drug is somewhat of a miracle drug for most people, although advertising it as such would be foolish. This is an anti-obesity drug which enables the users to fight their own issues with the ongoing battle of the bulge. (more…)

Detailed information about Acomplia

admin — Mon, 14 Jul 2008 12:18:57 +0000

Acomplia is a doctor prescribed medication that offers its patients the ability to rid themselves of both excess weight in addition to curbing their need to smoke. Studies show that weight gain is related to the quitting of smoking. All too often, people who smoke will say that the reason they don’t quit smoking is because they don’t want to gain the weight that they will inevitably gain. In addition, those folks who do manage to quit smoking find it hard to lose weight through exercise because they’ve caused damage to their lung capacity and breathing ability. (more…)

Fighting the effects of the demon alcohol

admin — Fri, 06 Jun 2008 13:53:29 +0000

One of the stereotypes of an alcoholic is that of an overweight individual. There are two main reasons for this The first is that people who spend a lot of their time drinking tend not to be physically active. They sit comfortably at home on a couch with bottles to hand, or lounge in a bar. Wherever they sit, the diet is also likely to be conveience based with is usually high in carbohydrates. The second reason is that alcohol itself has a direct “fat-building” effect. (more…)

Lose the weights for weight loss

admin — Mon, 19 May 2008 13:18:59 +0000

Whatever you read about acomplia and weight loss, there is one constant. Acomplia on its own cannot reduce your weight. It is designed to work alongside a low-calorie diet and physical exercise. So what kind of activity should people adopt? (more…)

Good news from Istanbul

admin — Mon, 05 May 2008 07:36:01 +0000

I am always impressed by a well-rounded acronym. It shows the research team is delighted by both science and language. In this case, we have the cumbersome An International Study of Rimonabant in Dyslipidemia with Atherogenic Risk in Abdominally Obese Patients distilled into the more convenient ADAGIO-LIPIDS. It is a shame that the team felt they had to cheat — I suppose AISRIDARAOP is not quite so catchy. Perhaps it works better in French. Two new reports based on the clinical trial of acomplia (generic name rimonabant) were presented on the 29th April in Istanbul at the 77th European Atherosclerosis Society Congress. (more…)

The United States is starting to take weight loss more seriously

admin — Fri, 25 Apr 2008 07:55:08 +0000

This April has been good news month in Philadelphia. According to a report published in Pediatrics, a research project to tackle obesity among children has been a success. Ten elementary schools were chosen, five instituted the weight loss program (although more local schools later began the program informally). Essentially, the proactive schools attacked the problem from three sides: through changing the food served in the cafeteria and sold through vending machines, by reintroducing physical exercise, and by teaching better lifestyles to both the children and their parents. (more…)

History of acomplia during 2007

admin — Fri, 18 Apr 2008 05:42:45 +0000

History is a strange beast. You can only see it when you turn and look back. The closer it is to you, the less easy it is to see. The difficulty with writing about acomplia is that you must always start somewhere. Wherever you pick in time, the real question is how far back to look. What have we taken for granted? What gaps have we left? So in this article, we catch up with the past. Just to make sure that we have everyone on the same virtual page. (more…)